[350 Pages Report] According to Future Market Insights (FMI), The Global Infant Nutritional Premix Market size was estimated at USD 235 million in 2021 and expected to reach USD 370 million in 2032, at 4%.
| Attribute | Details |
|---|---|
| Market Size Value in 2022 | US$ 235 Million |
| Market Forecast Value in 2032 | US$ 370 Million |
| Global Growth Rate (2022 to 2032) | 4.0% |
| Forecast Period | 2022-2032 |
| Market Share of India in South Asia | ~25% |
Over the projection period, demand for infant nutritional premix is expected to increase significantly. The increased need for convenient and nutritious infant food has resulted from the fast migration of working women in urban areas.
Consumer awareness of the possible health benefits of infant food has prompted them to consider these items as a viable alternative to nursing. By the end of 2032, the global market is expected to have grown by about twofold, reaching a value of USD 370 million.
Premix is a mixture in which all of the essential nutrient components are blended in the proper proportions. Infants require the optimal intake of vitamins and minerals to ensure effective postnatal growth and to decrease newborn morbidity and death. As a result, to meet their nutritional needs, newborns are fed a high-nutrient food premix. Infant nutrition is a broad category that encompasses a wide range of infant nourishment items for babies and infants.
Because of the rising knowledge about the benefits of newborn nutritional premixes produced with organic ingredients, vitamins, probiotics, and amino acids, they are becoming more widely used around the world.
Increased demand for infant nutritional premixes manufactured with purified protein, growing investment by key players to develop high-quality infant nutritional premixes, and a rise in innovations in infant nutritional premixes are the factors that are expected to drive the growth of the Infant Nutritional Premix Market from 2022 to 2032
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1 2021 | 4.0% |
| H1 2022 Projected | 4.0% |
| H1 2022 Expected | 4.4% |
| BPS Change | - 44 ↓ |
FMI presents a half-yearly comparison analysis and review of the market growth rates and further development prospects in the global market. The market is predominantly influenced by certain demographic and innovation factors under the subjective impact of macro and industry factors.
Some new developments that have taken place in these markets include:
The global market for Infant Nutritional Premix has witnessed H1 2021 growth at a magnitude of 4.0%. However, this growth is not evenly spread across all regions, with the developing markets recording higher growth rates of 4.4%. Thus, leaving a gap of -44 BPS points between expected and projected growth during H1 2022.
Key reasons for this change in growth rate are attributed to slow/rapid uptake of the market during the first half of the forecast period owing to improving end-user demand in key economies and their booming populations.
In particular, China and India are both seeing an increase in their consumption pattern, resulting in increased demand for the Infant Nutritional Premix market. Additionally, many other market segments are expected to perform fairly and attain promising growth prospects in the next half of the projection period.
Despite these positive prospects, there are some likely challenges that stay ahead for the industry including a shift in consumer preferences, stringent trade barriers, and a low degree of security in raw material supply, and other manufacturing inputs.
Because of the increased demand from health-conscious customers, significant firms around the world are working on advancements in medical food, particularly infant nutritional premixes.
One of the primary factors driving the growth of the Newborn Nutritional Premix Market is the increase in innovations in infant nutritional premixes with the addition of nucleotides, organic components, and probiotics.
Because of the growing knowledge of the benefits of fortified infant products, customers all over the world are increasingly turning to personalized premixes manufactured with pure protein. The leading companies throughout the world are also concentrating on producing customised mineral and vitamin premixes, which is driving the Infant Nutritional Premix Market even faster.
Over the forecast period, the United States will control over 36% of the global market, owing to the presence of important market players and a high consumption rate of baby nutritional products.
The cost of an infant automobile in the United States has risen dramatically in recent years. The average monthly cost of providing centre-based child care for an infant is USD 1,230 compared to USD 800 for a family child care home. The cost of child care for a newborn consumes 18% of a household's income on average.
Several producers have established themselves in the United States market. Similac Probiotic Tri-Blend, Similac Advance, and Similac Pro-Advance 20 are three of Abbott Nutrition's newborn premix formulations that help enhance the gut microbiome and perform as excellent breast milk substitutes.
In 2015, China's one-child policy was replaced with a two-child policy, with 17.5 million births recorded that year. This surge has had a significant impact on the baby food business, particularly on infant milk formula.
Children account for 1/3 of urban household expenditure in China, according to the National Bureau of Statistics. The majority of this money was spent on day-to-day baby feeding and meals for little children. RTD food items are becoming increasingly popular among Chinese parents since they are handy and can be tailored to their hectic schedules.
The newborn nutritional premixes market in China is being fueled by the aforementioned elements, as well as a rising desire for homemade, fresh, organic baby food. According to FMI, between 2022 and 2032, the market would increase at a CAGR of roughly 10%.
Principal Consultant
According to FMI, vitamin-based newborn nutritional premix accounted for about a third of the market share among all ingredients in 2020 and is predicted to expand at a rate of over 5% over the next decade.
The increased focus of parents on providing a nutritious meal for their children's health resulted in a demand for vitamin-based goods. To earn consumer trust, well-known brands such as Nestle-Ceregrow are meeting demand by introducing nutritious ingredients, such as essential vitamins for newborn newborns. Thickening and Binding Application is Boosting the Application Segment.
Powdered infant nutritional premixes accounted for the highest revenue share in 2021, and it is expected to continue on a favourable development trajectory with a CAGR of almost 6% over the forecast period.
The demand for powdered nutritious premixes is increasing dramatically in both developed countries and developing countries. This is due to the unique characteristics of powdered goods, such as their ease of water solubility.
The nutritional premixes market has seen a significant transition from liquid to powder form in recent years, owing to numerous benefits such as increased durability and simplicity.
Leading players are adopting novel strategies such as ground-breaking marketing tactics, the opening of new retail outlets, technical developments, and mergers and acquisitions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attribute | Details |
|---|---|
| Market Size Value in 2021 | US$ 235 Million |
| Market Forecast Value in 2032 | US$ 370 Million |
| Global Growth Rate | 4.0% |
| Forecast Period | 2022-2032 |
| Historical Data Available for | 2017-2021 |
| Market Analysis | MT for Volume and US$ Mn for Value |
| Key Regions Covered | North America; Latin America; Europe; Japan; APEJ and Middle East and Africa - MEA |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Argentina, EU5, Russia, Poland, China, ASEAN, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others. |
| Key Market Segments Covered | Nature, Grade, Application, End-Use and Regions |
| Key Companies Profiled | Glanbia Plc.; Koninklijke DSM N.V; SternVitamin GmbH & Co. AG; BASF SE; Lycored Limited; Watson Inc.; Fenchem Biotek Limited; Hexagon Nutrition Pvt. Ltd.; Jubilant Life Sciences; Farbest Brands; Prinova Group LLC; Barentz International B.V; Vitablend Nederland B.V; ADM; Vaneeghan International B.V |
By Form :
By Ingredient :
By Function :
By Distribution Channel :
By Region :
The market is likely to be worth US$ 370 million by 2032.
The market CAGR through 2032 is estimated to be 4%.
The United States leads the market with 36% market share.
The growth rate of vitamin-based infant products is 5%.
Businesses are investing into retail outlets as distribution channels to extend their reach.
1. Market Overview
1.1. Market Coverage / Taxonomy
1.2. Market Definition / Scope / Limitations
2. Scenario Assessment of the Impact of COVID-19 on Infant Nutritional Premix Market
2.1. Current Scenario / Immediate Actions
2.2. Global Infant Nutritional Premix Market Forecast Scenario Comparison of Annual Growth Rates for Short Term (2022-2026) and Long Term (2027-2032)
2.3. Key Factors Impacting the Market
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Technological Advancements /Shift in technology
4. Market Background
4.1. Product Processing Methods Overview
4.2. Consumer Buying Patterns & Tendencies
4.3. Policy Developments and Regulatory Scenario
4.4. Macro-Economic Factors
4.4.1. Global GDP Growth Outlook
4.4.2. Global Industry Value Added
4.4.3. Personal Consumption Expenditures
4.4.4. Modern Trade Penetration
4.4.5. Consumer Price Indices
4.5. Forecast Factors - Relevance & Impact
4.5.1. Production/Product Processing Capacity Growth
4.5.2. Trade Tariffs and Regulation Outlook
4.5.3. Global Food and Beverage Industry Outlook
4.6. Value Chain Analysis
4.6.1. Raw Material Sourcing
4.6.2. Infant Nutritional Premix Producers
4.7. Market Dynamics
4.7.1. Drivers
4.7.2. Restraints
4.7.3. Opportunity
5. Global Infant Nutritional Premix Market Demand Analysis 2017-2021 and Forecast, 2022-2032
5.1. Historical Market Volume (MT) Analysis, 2017-2021
5.2. Current and Future Market Volume (MT) Projections, 2022-2032
5.3. Y-o-Y Growth Trend Analysis Optimistic Scenario
6. Global Infant Nutritional Premix Market - Pricing Analysis
6.1. Regional Pricing Analysis (USD/MT) By Form
6.2. Global Average Pricing Analysis Benchmark
6.3. Key factors Impacting the Pricing
7. Global Infant Nutritional Premix Market Demand (Size in USD Mn) Analysis 2017-2021 and Forecast, 2022-2032
7.1. Historical Market Value (USD Mn) Analysis, 2017-2021
7.2. Current and Future Market Value (USD Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis Country of Operation
8. Global Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032, By Form
8.1. Introduction / Key Findings
8.2. Historical Market Size (USD Mn) and Volume (MT) Analysis By Form, 2017-2021
8.3. Current and Future Market Size (USD Mn) and Volume (MT) Analysis and Forecast By Form 2022-2032
8.3.1. Powder
8.3.2. Liquid
8.4. Market Attractiveness Analysis by Form
9. Global Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032, By Ingredient Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (USD Mn) and Volume (MT) Analysis by Ingredient Type, 2017-2021
9.3. Current and Future Market Size (USD Mn) and Volume (MT) Analysis and Forecast by Ingredient Type, 2022-2032
9.3.1. Vitamins
9.3.2. Minerals
9.3.3. Nucleotides
9.3.4. Amino Acid
9.3.5. Others
9.4. Market Attractiveness Analysis by Ingredient Type
10. Global Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032, By Function
10.1. Introduction / Key Findings
10.2. Historical Market Size (USD Mn) and Volume (MT) Analysis by Function, 2017-2021
10.3. Current and Future Market Size (USD Mn) and Volume (MT) Analysis and Forecast By Function, 2022-2032
10.3.1. Bone Health
10.3.2. Immunity
10.3.3. Digestion
10.3.4. Vision Health
10.3.5. Brain Health & Memory
10.3.6. Others
10.4. Market Attractiveness Analysis by Function
11. Global Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032, By Region
11.1. Introduction
11.2. Historical Market Size (USD Mn) and Volume (MT) Analysis By Region, 2017-2021
11.3. Current Market Size (USD Mn) and Volume (MT) Analysis and Forecast By Region, 2022-2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Western Europe
11.3.4. Eastern Europe
11.3.5. APAC
11.3.6. Japan
11.3.7. Middle East and Africa
11.4. Market Attractiveness Analysis By Region
12. North America Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032
12.1. Introduction
12.2. Historical Market Size (USD Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020
12.3. Market Size (USD Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031
12.3.1. By Country
12.3.1.1. U.S. (Market Share Analysis 2022)
12.3.1.1.1. By Form
12.3.1.1.2. By Ingredient Type
12.3.1.1.3. By Function
12.3.1.2. Canada (Market Share Analysis, 2022)
12.3.1.2.1. By Form
12.3.1.2.2. By Ingredient Type
12.3.1.2.3. By Function
12.3.2. By Form
12.3.3. By Ingredient Type
12.3.4. By Function
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Form
12.4.3. By Ingredient Type
12.4.4. By Function
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
13. Latin America Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Historical Market Size (USD Mn) and Volume Trend Analysis By Market Taxonomy, 2017-2021
13.3. Market Size (USD Mn) and Volume Forecast By Market Taxonomy, 2022-2032
13.3.1. By Country
13.3.1.1. Mexico (Market Share Analysis, 2022)
13.3.1.1.1. By Form
13.3.1.1.2. By Ingredient Type
13.3.1.1.3. By Function
13.3.1.2. Brazil (Market Share Analysis, 2022)
13.3.1.2.1. By Form
13.3.1.2.2. By Ingredient Type
13.3.1.2.3. By Function
13.3.1.3. Rest of LATAM (Market Share Analysis, 2022)
13.3.1.3.1. By Form
13.3.1.3.2. By Ingredient Type
13.3.1.3.3. By Function
13.3.2. By Form
13.3.3. By Ingredient Type
13.3.4. By Function
13.4. Market Attractiveness Analysis
13.4.1. By Form
13.4.2. By Ingredient Type
13.4.3. By Function
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
14. Western Europe Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Historical Market Size (USD Mn) and Volume Trend Analysis By Market Taxonomy, 2017-2021
14.3. Market Size (USD Mn) and Volume Forecast By Market Taxonomy, 2022-2032
14.3.1. By Country
14.3.1.1. Germany (Market Share Analysis, 2022)
14.3.1.1.1. By Form
14.3.1.1.2. By Ingredient Type
14.3.1.1.3. By Function
14.3.1.2. France (Market Share Analysis, 2022)
14.3.1.2.1. By Form
14.3.1.2.2. By Ingredient Type
14.3.1.2.3. By Function
14.3.1.3. Italy (Market Share Analysis, 2022)
14.3.1.3.1. By Form
14.3.1.3.2. By Ingredient Type
14.3.1.3.3. By Function
14.3.1.4. Spain (Market Share Analysis, 2022)
14.3.1.4.1. By Form
14.3.1.4.2. By Ingredient Type
14.3.1.4.3. By Function
14.3.1.5. U.K. (Market Share Analysis, 2022)
14.3.1.5.1. By Form
14.3.1.5.2. By Ingredient Type
14.3.1.5.3. By Function
14.3.1.6. BENELUX (Market Share Analysis, 2022)
14.3.1.6.1. By Form
14.3.1.6.2. By Ingredient Type
14.3.1.6.3. By Function
14.3.1.7. Nordic (Market Share Analysis, 2022)
14.3.1.7.1. By Form
14.3.1.7.2. By Ingredient Type
14.3.1.7.3. By Function
14.3.1.8. Rest of Western Europe (Market Share Analysis, 2022)
14.3.1.8.1. By Form
14.3.1.8.2. By Ingredient Type
14.3.1.8.3. By Function
14.3.2. By Form
14.3.3. By Ingredient Type
14.3.4. By Function
14.4. Market Attractiveness Analysis
14.4.1. By Form
14.4.2. By Ingredient Type
14.4.3. By Function
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
15. Eastern Europe Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Historical Market Size (USD Mn) and Volume Trend Analysis By Market Taxonomy, 2017-2021
15.3. Market Size (USD Mn) and Volume Forecast By Market Taxonomy, 2022-2032
15.3.1. By Country
15.3.1.1. Russia (Market Share Analysis, 2022)
15.3.1.1.1. By Form
15.3.1.1.2. By Ingredient Type
15.3.1.1.3. By Function
15.3.1.2. Poland (Market Share Analysis, 2022)
15.3.1.2.1. By Form
15.3.1.2.2. By Ingredient Type
15.3.1.2.3. By Function
15.3.1.3. Rest of Eastern Europe (Market Share Analysis, 2022)
15.3.1.3.1. By Form
15.3.1.3.2. By Ingredient Type
15.3.1.3.3. By Function
15.3.2. By Form
15.3.3. By Ingredient Type
15.3.4. By Function
15.4. Market Attractiveness Analysis
15.4.1. By Form
15.4.2. By Ingredient Type
15.4.3. By Function
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
16. APEC Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Historical Market Size (USD Mn) and Volume Trend Analysis By Market Taxonomy, 2017-2021
16.3. Market Size (USD Mn) and Volume Forecast By Market Taxonomy, 2022-2032
16.3.1. By Country
16.3.1.1. India (Market Share Analysis, 2022)
16.3.1.1.1. By Form
16.3.1.1.2. By Ingredient Type
16.3.1.1.3. By Function
16.3.1.2. Australia (Market Share Analysis, 2022)
16.3.1.2.1. By Form
16.3.1.2.2. By Ingredient Type
16.3.1.2.3. By Function
16.3.1.3. New Zealand (Market Share Analysis, 2022)
16.3.1.3.1. By Form
16.3.1.3.2. By Ingredient Type
16.3.1.3.3. By Function
16.3.1.4. ASEAN (Market Share Analysis, 2022)
16.3.1.4.1. By Form
16.3.1.4.2. By Ingredient Type
16.3.1.4.3. By Function
16.3.1.5. Rest of APAC (Market Share Analysis, 2022)
16.3.1.5.1. By Form
16.3.1.5.2. By Ingredient Type
16.3.1.5.3. By Function
16.3.2. By Form
16.3.3. By Ingredient Type
16.3.4. By Function
16.4. Market Attractiveness Analysis
16.4.1. By Form
16.4.2. By Ingredient Type
16.4.3. By Function
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
17. China Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Historical Market Size (USD Mn) and Volume Trend Analysis By Market Taxonomy, 2017-2021
17.3. Market Size (USD Mn) and Volume Forecast By Market Taxonomy, 2022-2032
17.3.1. By Country
17.3.2. By Form
17.3.3. By Ingredient Type
17.3.4. By Function
17.4. Market Attractiveness Analysis
17.4.1. By Form
17.4.2. By Ingredient Type
17.4.3. By Function
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
18. Middle East and Africa Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032
18.1. Introduction
18.2. Historical Market Size (USD Mn) and Volume Trend Analysis By Market Taxonomy, 2017-2021
18.3. Market Size (USD Mn) and Volume Forecast By Market Taxonomy, 2022-2032
18.3.1. By Country
18.3.1.1. GCC Countries (Market Share Analysis, 2022)
18.3.1.1.1. By Form
18.3.1.1.2. By Ingredient Type
18.3.1.1.3. By Function
18.3.1.2. South Africa (Market Share Analysis, 2022)
18.3.1.2.1. By Form
18.3.1.2.2. By Ingredient Type
18.3.1.2.3. By Function
18.3.1.3. North Africa (Market Share Analysis, 2022)
18.3.1.3.1. By Form
18.3.1.3.2. By Ingredient Type
18.3.1.3.3. By Function
18.3.1.4. Rest of MEA (Market Share Analysis, 2022)
18.3.1.4.1. By Form
18.3.1.4.2. By Ingredient Type
18.3.1.4.3. By Function
18.3.2. By Form
18.3.3. By Ingredient Type
18.3.4. By Function
18.4. Market Attractiveness Analysis
18.4.1. By Form
18.4.2. By Ingredient Type
18.4.3. By Function
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
19. Key Countries Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032
19.1. U.S.
19.1.1. Introduction
19.1.2. Pricing Analysis (2017, 2022, 2032)
19.1.3. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.1.3.1.1. By Form
19.1.3.1.2. By Ingredient Type
19.1.3.1.3. By Function
19.2. Canada
19.2.1. Pricing Analysis (2017, 2022, 2032)
19.2.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.2.2.1.1. By Form
19.2.2.1.2. By Ingredient Type
19.2.2.1.3. By Function
19.3. Brazil
19.3.1. Pricing Analysis (2017, 2022, 2032)
19.3.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.3.2.1.1. By Form
19.3.2.1.2. By Ingredient Type
19.3.2.1.3. By Function
19.4. Mexico
19.4.1. Pricing Analysis (2017, 2022, 2032)
19.4.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.4.2.1.1. By Form
19.4.2.1.2. By Ingredient Type
19.4.2.1.3. By Function
19.5. Germany
19.5.1. Pricing Analysis (2017, 2022, 2032)
19.5.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.5.2.1.1. By Form
19.5.2.1.2. By Ingredient Type
19.5.2.1.3. By Function
19.6. Italy
19.6.1. Pricing Analysis (2017, 2022, 2032)
19.6.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.6.2.1.1. By Form
19.6.2.1.2. By Ingredient Type
19.6.2.1.3. By Function
19.7. France
19.7.1. Pricing Analysis (2017, 2022, 2032)
19.7.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.7.2.1.1. By Form
19.7.2.1.2. By Ingredient Type
19.7.2.1.3. By Function
19.8. U.K.
19.8.1. Pricing Analysis (2017, 2022, 2032)
19.8.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.8.2.1.1. By Form
19.8.2.1.2. By Ingredient Type
19.8.2.1.3. By Function
19.9. Spain
19.9.1. Pricing Analysis (2017, 2022, 2032)
19.9.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.9.2.1.1. By Form
19.9.2.1.2. By Ingredient Type
19.9.2.1.3. By Function
19.10. Benelux
19.10.1. Pricing Analysis (2017, 2022, 2032)
19.10.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.10.2.1.1. By Form
19.10.2.1.2. By Ingredient Type
19.10.2.1.3. By Function
19.11. Russia
19.11.1. Pricing Analysis (2017, 2022, 2032)
19.11.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.11.2.1.1. By Form
19.11.2.1.2. By Ingredient Type
19.11.2.1.3. By Function
19.12. Nordic
19.12.1. Pricing Analysis (2017, 2022, 2032)
19.12.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.12.2.1.1. By Form
19.12.2.1.2. By Ingredient Type
19.12.2.1.3. By Function
19.13. Poland
19.13.1. Pricing Analysis (2017, 2022, 2032)
19.13.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.13.2.1.1. By Form
19.13.2.1.2. By Ingredient Type
19.13.2.1.3. By Function
19.14. India
19.14.1. Pricing Analysis (2017, 2022, 2032)
19.14.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.14.2.1.1. By Form
19.14.2.1.2. By Ingredient Type
19.14.2.1.3. By Function
19.15. Australia
19.15.1. Pricing Analysis (2017, 2022, 2032)
19.15.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.15.2.1.1. By Form
19.15.2.1.2. By Ingredient Type
19.15.2.1.3. By Function
19.16. New Zealand
19.16.1. Pricing Analysis (2017, 2022, 2032)
19.16.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.16.2.1.1. By Form
19.16.2.1.2. By Ingredient Type
19.16.2.1.3. By Function
19.17. ASEAN
19.17.1. Pricing Analysis (2017, 2022, 2032)
19.17.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.17.2.1.1. By Form
19.17.2.1.2. By Ingredient Type
19.17.2.1.3. By Function
19.18. China
19.18.1. Pricing Analysis (2017, 2022, 2032)
19.18.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.18.2.1.1. By Form
19.18.2.1.2. By Ingredient Type
19.18.2.1.3. By Function
19.19. GCC Countries
19.19.1. Pricing Analysis (2017, 2022, 2032)
19.19.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.19.2.1.1. By Form
19.19.2.1.2. By Ingredient Type
19.19.2.1.3. By Function
19.20. South Africa
19.20.1. Pricing Analysis (2017, 2022, 2032)
19.20.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.20.2.1.1. By Form
19.20.2.1.2. By Ingredient Type
19.20.2.1.3. By Function
19.21. North Africa
19.21.1. Pricing Analysis (2017, 2022, 2032)
19.21.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032
19.21.2.1.1. By Form
19.21.2.1.2. By Ingredient Type
19.21.2.1.3. By Function
20. Market Structure Analysis- Global Assessment
20.1. Company Dashboard
20.2. Industry Structure Analysis by Tier of Companies, 2021E
20.3. Company Share Analysis of Top Players, 2021E
20.3.1. Company Share By Form
20.3.2. Company Share By Region
20.4. Competition Benchmarking- Matrix
21. Competition Deep Dive (Tentative List)
21.1. Competition Deep Dive
21.1.1. Glanbia Plc
21.1.1.1. Overview
21.1.1.2. Product Portfolio
21.1.1.3. Profitability by Market Segments
21.1.1.4. Sales Footprint
21.1.1.5. Strategy Overview
21.1.1.5.1. Product Strategy
21.1.2. Royal DSM N.V
21.1.2.1. Overview
21.1.2.2. Product Portfolio
21.1.2.3. Profitability by Market Segments
21.1.2.4. Sales Footprint
21.1.2.5. Strategy Overview
21.1.2.5.1. Product Strategy
21.1.3. SternVitamin GmbH & CO. KG
21.1.3.1. Overview
21.1.3.2. Product Portfolio
21.1.3.3. Profitability by Market Segments
21.1.3.4. Sales Footprint
21.1.3.5. Strategy Overview
21.1.3.5.1. Product Strategy
21.1.3.6. BASF SE Overview
21.1.3.7. Product Portfolio
21.1.3.8. Profitability by Market Segments
21.1.3.9. Sales Footprint
21.1.3.10. Strategy Overview
21.1.3.10.1. Product Strategy
21.1.4. Lycored Limited
21.1.4.1. Overview
21.1.4.2. Product Portfolio
21.1.4.3. Profitability by Market Segments
21.1.4.4. Sales Footprint
21.1.4.5. Strategy Overview
21.1.4.5.1. Product Strategy
21.1.5. Watson-Inc.
21.1.5.1. Overview
21.1.5.2. Product Portfolio
21.1.5.3. Profitability by Market Segments
21.1.5.4. Sales Footprint
21.1.5.5. Strategy Overview
21.1.5.5.1. Product Strategy
21.1.6. Fenchem biotek Ltd
21.1.6.1. Overview
21.1.6.2. Product Portfolio
21.1.6.3. Profitability by Market Segments
21.1.6.4. Sales Footprint
21.1.6.5. Strategy Overview
21.1.6.5.1. Product Strategy
21.1.7. Hexagon Nutrition Pvt. Ltd.
21.1.7.1. Overview
21.1.7.2. Product Portfolio
21.1.7.3. Profitability by Market Segments
21.1.7.4. Sales Footprint
21.1.7.5. Strategy Overview
21.1.7.5.1. Product Strategy
21.1.8. Jubilant Life Sciences Limited
21.1.8.1. Overview
21.1.8.2. Product Portfolio
21.1.8.3. Profitability by Market Segments
21.1.8.4. Sales Footprint
21.1.8.5. Strategy Overview
21.1.8.5.1. Product Strategy
21.1.9. Archer Daniel Midlands Company
21.1.9.1. Overview
21.1.9.2. Product Portfolio
21.1.9.3. Profitability by Market Segments
21.1.9.4. Sales Footprint
21.1.9.5. Strategy Overview
21.1.9.5.1. Product Strategy
21.1.10. Farbest Brands
21.1.10.1. Overview
21.1.10.2. Product Portfolio
21.1.10.3. Profitability by Market Segments
21.1.10.4. Sales Footprint
21.1.10.5. Strategy Overview
21.1.10.5.1. Product Strategy
21.1.11. Prinova Group
21.1.11.1. Overview
21.1.11.2. Product Portfolio
21.1.11.3. Profitability by Market Segments
21.1.11.4. Sales Footprint
21.1.11.5. Strategy Overview
21.1.11.5.1. Product Strategy
21.1.12. Others on Additional Request
21.1.12.1. Overview
21.1.12.2. Product Portfolio
21.1.12.3. Profitability by Market Segments
21.1.12.4. Sales Footprint
21.1.12.5. Strategy Overview
21.1.12.5.1. Product Strategy
Note: Above list is subjected to change during the course of study
22. Assumptions and Acronyms Used
23. Research Methodology
Explore Food and Beverage Insights
View Reports
Infant Nutritional Premix Market
